§ 2-37-105 — Labeling

Arkansas § 2-37-105

• Jurisdiction: Arkansas
• Title: 2

Text

A commercial feed shall be labeled as follows: (a) In the case of a commercial feed, except a customer-formula feed, it shall be accompanied by a label bearing the following information: (1) The quantity statement (may be stated in metric units in addition to the required avoirdupois). (2) The product name and brand name, if any, under which the commercial feed is distributed. (3) The guaranteed analysis stated in such terms as the State Plant Board by rule determines is required to advise the user of the composition of the feed or to support claims made in the labeling. In all cases the substances or elements must be determinable by laboratory methods such as the methods published by the AOAC International. (4) The common or usual name of each ingredient used in the manufacture of the commercial feed, provided that the board by rule may permit the use of a collective term for a group of ingredients which perform a similar function, or the board may exempt such commercial feeds, or any group thereof, from this requirement of an ingredient statement if the board finds that such statement is not required in the interest of consumers. (5) The name and principal mailing address of the manufacturer or the person responsible for distributing the commercial feed. (6) Adequate directions for use for all commercial feeds containing drugs and for such other feeds as the board may require by rule as necessary for their safe and effective use. (7) Such precautionary statements as the board by rule determines are necessary for the safe and effective use of the commercial feed. (8) If a drug containing product is used: (A) The purpose of the medication (claim statement), and (B) The established name of each active drug ingredient and the level of each drug used in the final mixture expressed as defined by rule. (b) In the case of a customer-formula feed, it shall be accompanied by a label, invoice, delivery slip or other shipping document, bearing the following information: (1) Name and address of the manufacturer; (2) Name and address of the purchaser; (3) Date of delivery; (4) The product name and net weight (may be stated in metric units in addition to the required avoirdupois) of each commercial feed and each other ingredient used in the mixture; (5) Adequate directions for use and precautionary statements for all customer-formula feeds containing drugs and for such other feeds as the board may require by rule as necessary for their safe and effective use. (6) If a drug containing product is used: (A) The purpose of the medication (claim statement); and (B) The established name of each active drug ingredient and the level of each drug used in the final mixture expressed as defined by rule.

Legislative History

Amended by Act 2019, No. 315,§ 25, eff. 7/24/2019. Amended by Act 2019, No. 315,§ 24, eff. 7/24/2019. Amended by Act 2019, No. 315,§ 23, eff. 7/24/2019. Acts 1997, No. 726, § 5.